FDA inspection
Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.: FDA inspection ending Nov 10, 2023
FDA inspection 1223918 · No Action Indicated (NAI) · Wujin, Changzhou
Key facts
| Inspection ID | 1223918 |
|---|---|
| Firm | Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. |
| FEI number | 3004175957 |
| Address | Daixi 1 No.35, Yixi Road; Luoyangzhen Wujin |
| City | Wujin, Changzhou |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Nov 10, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data